MedPath

Ulcer Monitoring in Diabetes Mellitus

Phase 2
Conditions
Diabetes Mellitus
Foot Ulcers
Interventions
Procedure: telemedicine consultations
Registration Number
NCT01608425
Lead Sponsor
Johnny Froekjaer
Brief Summary

Telemedicine technology enables a direct and online text- and image communication in the treatment system from patient to the ulcer specialist. The technology is expected to have patient-related, economic and therapeutic benefits. The study is a substudy of a larger project entitled "Renewing Health", where also the economic and management aspects are highlighted. However, only few randomized prospective studies are conducted in this field. The purpose of the study is in a randomized prospective study, to assess the impact of the introduction of the telemedicine technology as consultation form between ulcer-nurses in the primary sector and the wound clinics at the hospitals in the region. It is assessed whether the technology can be adopted without incurring the patient a risk. The study aims to perform an impact analysis of the introduction of new technologies for telemedicine wound monitoring in the treatment of diabetic foot ulcers through different studies.

Detailed Description

Through randomized and prospective studies the project will show whether a telemedicine approach to wound care can be used as an alternative to traditional attendance at a wound clinic and document whether this consultation form provides a greater patient-satisfaction and cost savings. The project will document that telemedicine is equivalent to conventional outpatient attendance from a therapeutic aspect in terms of number of hospitalizations, number of extra controls, acute interventions and wound healing.

The project is also investigating the extent of time spent on the personnel side using telemedicine consultations compared with conventional outpatient appearances.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Having diabetic foot ulcer
  • Referred for out-patient clinic treatment by general practitioner
  • Referred for out-patient clinic treatment by a surgical department
  • Living in Region of Southern Denmark
Exclusion Criteria
  • Psychiatric disorder
  • Dementia
  • Chronic alcohol abuse which can affect compliance
  • Other disorder then diabetes mellitus that have caused foot ulcer (rheumatoid arthritis or arthritis urica)
  • Serious kidney disease which requires dialysis
  • Previous foot ulcer - which was part of the study
  • Expected healing within 2-4 weeks where only one control (final) is expected

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Diabetes ulcer monitoringtelemedicine consultationsReceives a telemedicine intervention: Diabetes ulcer monitoring.
Primary Outcome Measures
NameTimeMethod
Admissions to hospitalfrom time of inclusion until treatment completed, assessed up to 52 weeks

The number of admissions, incl, beddays, to hospital relating to ulcer treatment for each randomised patient during the treatment period.

Surgical proceduresfrom time of inclusion until completed treatment, assessed up to 52 weeks

The number of surgical procedures (incl. amputations) performed at hospital in realtion to the ulcer during the treatment period.

Secondary Outcome Measures
NameTimeMethod
Ulcer healingProgress is measured at minimum every 4 weeks during treatment period, assessed up to 52 weeks

The time from inclusion and start of treatment until ulcer is healed and treatment is stopped.

Trial Locations

Locations (6)

Hospital Lillebaelt

🇩🇰

Vejle, Region of Southern Denmark, Denmark

Svendborg Hospital

🇩🇰

Svendborg, Region of Southern Denmark, Denmark

Odense University Hospital

🇩🇰

Odense, Region of Southern Denmark, Denmark

Hospital South Jutland

🇩🇰

Soenderborg, Region of Southern Denmark, Denmark

South-west Hospital

🇩🇰

Esbjerg, Region of Southern Denmark, Denmark

Lillebaelt Hospital

🇩🇰

Kolding, Region of Southern Denmark, Denmark

© Copyright 2025. All Rights Reserved by MedPath